Pharmacology and Regulation of Appetite and Food Intake

Affiliations

¹ Department of Medical and Health Sciences, School of Health and Human Development, MED-Mediterranean Institute for Agriculture, Environment and Development & CHANGE-Global Change and Sustainability Institute, University of Évora, Évora, Portugal.
² MED-Mediterranean Institute for Agriculture, Environment and Development & CHANGE-Global Change and Sustainability Institute, University of Évora, Évora, Portugal.
³ Department of Medical and Health Sciences, School of Health and Human Development, CHRC-Comprehensive Health Research Centre, LA REAL-Associated Laboratory in Translation and Innovation Towards Global Health, University of Évora, Évora, Portugal.

Editorial

Fernando Capela E Silva et al. Pharmacol Res Perspect. 2025 Aug.

. 2025 Aug;13(4):e70101.

doi: 10.1002/prp2.70101.

¹ Department of Medical and Health Sciences, School of Health and Human Development, MED-Mediterranean Institute for Agriculture, Environment and Development & CHANGE-Global Change and Sustainability Institute, University of Évora, Évora, Portugal.
² MED-Mediterranean Institute for Agriculture, Environment and Development & CHANGE-Global Change and Sustainability Institute, University of Évora, Évora, Portugal.
³ Department of Medical and Health Sciences, School of Health and Human Development, CHRC-Comprehensive Health Research Centre, LA REAL-Associated Laboratory in Translation and Innovation Towards Global Health, University of Évora, Évora, Portugal.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

1. Clarke G. S., Page A. J., and Eldeghaidy S., “The Gut‐Brain Axis in Appetite, Satiety, Food Intake, and Eating Behavior: Insights From Animal Models and Human Studies,” Pharmacology Research & Perspectives 12, no. 5 (2024): e70027, 10.1002/prp2.70027. - DOI - PMC - PubMed
1. Rubinić I., Kurtov M., and Likić R., “Novel Pharmaceuticals in Appetite Regulation: Exploring Emerging Gut Peptides and Their Pharmacological Prospects,” Pharmacology Research & Perspectives 12, no. 4 (2024): e1243, 10.1002/prp2.1243. - DOI - PMC - PubMed
1. Kurtov M., Rubinić I., and Likić R., “The Endocannabinoid System in Appetite Regulation and Treatment of Obesity,” Pharmacological Research Perspectives 12, no. 5 (2024): e70009, 10.1002/prp2.70009. - DOI - PMC - PubMed
1. Lord M. N. and Noble E. E., “Hypothalamic Cannabinoid Signaling: Consequences for Eating Behavior,” Pharmacology Research & Perspectives 12, no. 5 (2024): e1251, 10.1002/prp2.1251. - DOI - PMC - PubMed
1. Mondal S., Rathor R., Singh S. N., and Suryakumar G., “miRNA and Leptin Signaling in Metabolic Diseases and at Extreme Environments,” Pharmacology Research & Perspectives 12, no. 4 (2024): e1248, 10.1002/prp2.1248. - DOI - PMC - PubMed